Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
NCT05750706 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-05-06
Summary
The study aims to evaluate incidence of invasive antifungal infections among patients with acute lymphoblastic leukemia Ph negative during the first weeks of treatment
Conditions
- Acute Lymphoblastic Leukemia, Adult
- Invasive Fungal Infections
Interventions
- OTHER
-
observation of invasive fungal infections
observation of invasive fungal infections during chemotherapy
Sponsors & Collaborators
-
Asst Degli Spedali Civili Di Brescia
collaborator OTHER -
IRCCS Azienda Ospedaliero-Universitaria di Bologna
collaborator OTHER -
Campus Bio-Medico University
collaborator OTHER -
Azienda Sanitaria Universitaria Friuli Centrale
collaborator OTHER -
San Gallicano Dermatological Institute IRCCS
collaborator OTHER -
University of Rome Tor Vergata
collaborator OTHER -
University of Modena and Reggio Emilia
collaborator OTHER -
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
collaborator OTHER -
Vito Fazzi Hospital
collaborator UNKNOWN -
Azienda Ospedaliera di Padova
collaborator OTHER -
San Raffaele University Hospital, Italy
collaborator OTHER -
Azienda Ospedaliera Universitaria Integrata Verona
collaborator OTHER -
Azienda Ospedaliero-Universitaria di Parma
collaborator OTHER -
Azienda Ospedaliera "Sant'Andrea"
collaborator OTHER -
S.Eugenio Hospital
collaborator OTHER -
San Giovanni Addolorata Hospital
collaborator OTHER -
Casa Sollievo della Sofferenza-IRCCS, San Giovanni Rotondo
collaborator UNKNOWN -
ASST Sette Laghi
collaborator OTHER -
Ospedale San Bortolo di Vicenza
collaborator OTHER -
Fondazione IRCCS Policlinico San Matteo di Pavia
collaborator OTHER -
A.O.U. Città della Salute e della Scienza
collaborator OTHER -
Istituto Oncologico Veneto IRCCS
collaborator OTHER -
Azienda Ospedaliera San Gerardo di Monza
collaborator OTHER -
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
collaborator OTHER -
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
lead OTHER
Principal Investigators
-
Marianna Criscuolo · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2026-03-31
- Completion
- 2026-03-31
Countries
- Italy
Study Locations
More Related Trials
-
Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy
NCT05249894 ·Status: UNKNOWN
-
Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients
NCT01578213 ·Status: COMPLETED ·Phase: PHASE4
-
Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia
NCT03367299 ·Status: COMPLETED ·Phase: PHASE2
-
Genotyping Analysis of Acute Lymphoblastic Leukemia
NCT00961285 ·Status: UNKNOWN
-
Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy
NCT01490853 ·Status: COMPLETED
-
A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
NCT03913949 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
"Triple Negative" Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL
NCT06919393 ·Status: RECRUITING
-
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
NCT05147467 ·Status: RECRUITING ·Phase: PHASE2
-
French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings
NCT05590702 ·Status: ACTIVE_NOT_RECRUITING
-
Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients
NCT02010931 ·Status: COMPLETED
-
Selenious Yeast in CLL Patients w/o Indication of Chemotherapy
NCT05136378 ·Status: RECRUITING ·Phase: NA
-
Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
NCT02856178 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
NCT05929976 ·Status: RECRUITING
-
Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia
NCT00188084 ·Status: UNKNOWN
-
Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
NCT03318770 ·Status: UNKNOWN
-
Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.
NCT01785914 ·Status: UNKNOWN
-
Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia
NCT00936117 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
NCT03647124 ·Status: COMPLETED
-
Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia
NCT03187691 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
NCT03509896 ·Status: COMPLETED
-
Lenalidomide, Fludarabine & Cyclophosphamide in Advanced Chronic Lymphocytic Leukemia Not Responding to Therapy
NCT00727415 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
NCT05748197 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)
NCT04849416 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia
NCT06814444 ·Status: RECRUITING
-
Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL
NCT03502876 ·Status: COMPLETED